Esophageal cancer is combined modality treatment. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Esophagus Cell Line, Tumor Mucous Membrane Tumor Cells, Cultured Esophagogastric Junction Cardia Lymph Nodes Organs at Risk Neoplastic Stem Cells Breast Upper Gastrointestinal Tract

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases52

Esophageal Neoplasms Hodgkin Disease Carcinoma, Squamous Cell Lung Neoplasms Adenocarcinoma Stomach Neoplasms Neoplasm Invasiveness Neoplasm Metastasis Neoplasms Breast Neoplasms Carcinoma Prostatic Neoplasms Genetic Predisposition to Disease Barrett Esophagus Neoplasms, Squamous Cell Colonic Neoplasms Ovarian Neoplasms Neoplasm Recurrence, Local Precancerous Conditions Neoplasms, Second Primary Pancreatic Neoplasms Disease Progression Neoplasms, Multiple Primary Esophageal Stenosis Gastrointestinal Neoplasms Lymphatic Metastasis Esophagitis Pharyngeal Neoplasms Thoracic Neoplasms Cell Transformation, Neoplastic Colorectal Neoplasms Mouth Neoplasms Uterine Cervical Neoplasms Head and Neck Neoplasms Deglutition Disorders Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Carcinoma, Adenosquamous Radiation Injuries Liver Neoplasms Rectal Neoplasms Neovascularization, Pathologic Hypopharyngeal Neoplasms Endometrial Neoplasms Esophageal Fistula Postoperative Complications Digestive System Neoplasms Bone Neoplasms Papillomavirus Infections Carcinoma, Small Cell Tracheal Stenosis Disease Models, Animal

Chemicals and Drugs57

Mechlorethamine Procarbazine Vincristine Cisplatin Fluorouracil Prednisone Cyclophosphamide Doxorubicin Aldehyde Dehydrogenase Tumor Markers, Biological Neoplasm Proteins Antineoplastic Agents RNA, Messenger Opium Radiopharmaceuticals DNA, Neoplasm Cancer Vaccines Tumor Suppressor Protein p53 Paclitaxel Dimethylnitrosamine Antigens, Neoplasm RNA, Small Interfering Receptor, erbB-2 Antineoplastic Agents, Phytogenic Fluorodeoxyglucose F18 MicroRNAs Transferrins Anticarcinogenic Agents Receptors, Estrogen Alcohol Dehydrogenase Tea Carcinogens Fumonisins Acetaldehyde Receptor, Epidermal Growth Factor Cyclooxygenase 2 Prostate-Specific Antigen RNA, Neoplasm Taxoids Glutathione Transferase Organoplatinum Compounds Carcinogens, Environmental Antibodies, Monoclonal Antimetabolites, Antineoplastic Tumor Suppressor Proteins 4-Nitroquinoline-1-oxide Carcinoembryonic Antigen Tamoxifen Glutathione S-Transferase pi DNA-Binding Proteins Radiation-Sensitizing Agents Antineoplastic Agents, Hormonal Receptors, Progesterone Cytochrome P-450 CYP2E1 Mycotoxins HLA-A24 Antigen Methylenetetrahydrofolate Reductase (NADPH2)

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Combined Modality Therapy Esophagectomy Antineoplastic Combined Chemotherapy Protocols Radiotherapy Dosage Neoplasm Staging Radiotherapy Survival Rate Radiotherapy, Adjuvant Survival Analysis Treatment Outcome Retrospective Studies Early Detection of Cancer Esophagoscopy Prognosis Chemoradiotherapy Risk Factors Esophagostomy Follow-Up Studies Incidence Reverse Transcriptase Polymerase Chain Reaction Neoadjuvant Therapy Positron-Emission Tomography Risk Prospective Studies Chemotherapy, Adjuvant Registries Sensitivity and Specificity Risk Assessment Odds Ratio Case-Control Studies Lymph Node Excision Xenograft Model Antitumor Assays Disease-Free Survival Tomography, X-Ray Computed Gene Expression Profiling Kaplan-Meier Estimate Immunohistochemistry Multivariate Analysis Polymerase Chain Reaction Palliative Care Tumor Burden Blotting, Western Reproducibility of Results Predictive Value of Tests Confidence Intervals Endosonography Neoplasm Transplantation Chemoradiotherapy, Adjuvant Biopsy Endoscopy Logistic Models Preoperative Care Transplantation, Heterologous Oligonucleotide Array Sequence Analysis SEER Program Questionnaires Dose Fractionation Tissue Array Analysis Multimodal Imaging Drug Administration Schedule Transfection Gastrostomy Radiotherapy, Conformal Cohort Studies Drug Screening Assays, Antitumor Immunoenzyme Techniques Clinical Trials as Topic Gene Knockdown Techniques Radiotherapy Planning, Computer-Assisted Diagnostic Imaging Mammography Gastrectomy Feasibility Studies Thoracoscopy Dose-Response Relationship, Radiation Postoperative Period Chi-Square Distribution Molecular Targeted Therapy Disease Models, Animal DNA Mutational Analysis

Psychiatry and Psychology3

Alcohol Drinking Smoking Food Habits

Phenomena and Processes37

Time Factors Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Risk Sensitivity and Specificity Polymorphism, Genetic Odds Ratio Genotype Drug Resistance, Neoplasm Mutation DNA Methylation Apoptosis Genes, p53 Down-Regulation Cell Proliferation Cell Survival Diet Cell Movement Cell Division Radiation Tolerance Dose-Response Relationship, Drug Up-Regulation Promoter Regions, Genetic Alleles Cell Growth Processes Transfection Cell Cycle RNA Interference Genes, Tumor Suppressor Base Sequence Diet Fads Gene Expression Gene Silencing Signal Transduction Dose-Response Relationship, Radiation Genes, BRCA1 Chi-Square Distribution

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Diet Fads

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science9

Survival Rate Incidence Registries SEER Program Questionnaires Radiotherapy, Conformal Base Sequence Radiotherapy Planning, Computer-Assisted Molecular Sequence Data

Named Groups3

Asian Continental Ancestry Group Survivors European Continental Ancestry Group

Health Care35

Survival Rate Survival Analysis Treatment Outcome Retrospective Studies Risk Factors Follow-Up Studies Incidence Risk Prospective Studies Registries Sensitivity and Specificity Risk Assessment Odds Ratio Case-Control Studies Disease-Free Survival Kaplan-Meier Estimate Age Factors Multivariate Analysis Palliative Care Reproducibility of Results Predictive Value of Tests Confidence Intervals Logistic Models Preoperative Care Radiation Injuries National Cancer Institute (U.S.)SEER Program Questionnaires Cohort Studies Clinical Trials as Topic Feasibility Studies Dose-Response Relationship, Radiation Postoperative Period Chi-Square Distribution Sex Factors

Geographicals7

China Iran Japan United States Paraguay Azerbaijan Kazakhstan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Esophageal Neoplasms Combined Modality Therapy Esophagectomy Mechlorethamine Procarbazine Hodgkin Disease Antineoplastic Combined Chemotherapy Protocols Radiotherapy Dosage Carcinoma, Squamous Cell Neoplasm Staging Radiotherapy Vincristine Survival Rate Radiotherapy, Adjuvant Cisplatin Fluorouracil Lung Neoplasms Survival Analysis Treatment Outcome Retrospective Studies Esophagus Adenocarcinoma Prednisone Cyclophosphamide Time Factors China Early Detection of Cancer Esophagoscopy Doxorubicin Prognosis Stomach Neoplasms Chemoradiotherapy Gene Expression Regulation, Neoplastic Cell Line, Tumor Risk Factors Neoplasm Invasiveness Esophagostomy Follow-Up Studies Neoplasm Metastasis Neoplasms Breast Neoplasms Iran Carcinoma Mice, Nude Prostatic Neoplasms Aldehyde Dehydrogenase Genetic Predisposition to Disease Barrett Esophagus Neoplasms, Squamous Cell Colonic Neoplasms Ovarian Neoplasms Tumor Markers, Biological Neoplasm Proteins Alcohol Drinking Incidence Antineoplastic Agents Smoking Neoplasm Recurrence, Local Reverse Transcriptase Polymerase Chain Reaction Neoadjuvant Therapy Positron-Emission Tomography Risk Prospective Studies Precancerous Conditions Chemotherapy, Adjuvant Registries Sensitivity and Specificity Risk Assessment Polymorphism, Genetic Odds Ratio Neoplasms, Second Primary Case-Control Studies Pancreatic Neoplasms Disease Progression Lymph Node Excision RNA, Messenger Neoplasms, Multiple Primary Xenograft Model Antitumor Assays Disease-Free Survival Opium Esophageal Stenosis Genotype Tomography, X-Ray Computed Radiopharmaceuticals Japan DNA, Neoplasm Cancer Vaccines Gene Expression Profiling Kaplan-Meier Estimate Gastrointestinal Neoplasms Tumor Suppressor Protein p53 Immunohistochemistry Lymphatic Metastasis Age Factors Drug Resistance, Neoplasm Multivariate Analysis Esophagitis Pharyngeal Neoplasms Polymerase Chain Reaction Palliative Care

No FAQ available that match "esophageal cancer is combined modality treatment"